Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of a Reduced-toxicity " Submyeloablative " Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

NCT00841724 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT00841724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of a Reduced-toxicity " Submyeloablative " Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
January 31, 2012
Enrollment
82 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies